Effects of the thromboxane a2 receptor antagonist on platelet deposition and intimal hyperplasia after balloon injury

Japanese Heart Journal

Volumn 40, Issue 6, 1999, Pages 791-802

  Yamagami, Shinichiro ^a   Miyauchi, Katsumi ^a   Kimura, Tohru ^a   Goh, Yasumasa ^a   Daida, Hiroyuki ^a   Yamaguchi, Hiroshi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angioplasty; Local delivery; Platelet deposition; Restenosis; S 1452; Smooth muscle cells; Thromboxane A2 receptor antagonist

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CHOLESTEROL; DOMITROBAN; INDIUM 111; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON; BLOOD VESSEL INJURY; CONTROLLED STUDY; DIET; FAT INTAKE; ILIAC ARTERY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESTENOSIS; THROMBOCYTE AGGREGATION;

EID: 0033507702     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.40.791     Document Type: Article

References (29)

1. Vliestra RE, Holmes DR, Piehler JM, et al. Balloon angioplasty in multivessel coronary artery disease. Mayo Clin Proc 1983; 58: 563-7.
2. Faxon DP, Kelsey SF, Ryan TJ, McCabe CH, Detre K. Determination of successful percutaneous transluminal coronary angioplasty: report from the National Heart, Lung and Blood Institute Registry. Am Heart J 1984; 108: 1019-23.
3. Holmes DR, Vliestra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung and Blood Institute. Am J Cardiol 1984; 53: 77C-81.
4. McBride W, Lange RA, Hillis LD. Restenosis after successful coronary angioplasty. N Eng J Med 1988; 318: 1734-7.
5. Ip JH, Fuster V, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15: 1667-87.
6. Steele PM, Chesebro JH, Fuster V, et al. Balloon angioplasty: natural history of the pathophysiologic response to injury. Circ Res 1985; 57: 105-12.
7. Ellis EF, Oelz O, Oates JA, et al. Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science 1976; 193: 1135-7.
8. Ogletree ML. Overview of physiological and pathophysiological effects of thromboxane A2. Fed Proc 1987; 46: 133-8.
9. Barnathan ES, Schwartz JS, Hirshfeld JW, et al. Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. Circulation 1987; 76: 125-34.
10. Serruys PW, Rutsch W, Stibbe J, et al. Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2 receptor blockade: a randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane A2 Antagonism Study (CARPORT). Circulation 1991; 84: 1568-80.
11. Savage M, Goldberg S, Pepine CJ, et al. Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty: Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II). Circulation 1995; 92: 3194-200.
12. Hanasaki K, Nakano K, Kasai H, Arita H. Biochemical characterization and comparison of rat thromboxane A2/prostaglandin H2 receptors in platelets and cultured aortic smooth muscle cells. Biochem Pharmacol 1989; 38: 2967-76.
13. Hanasaki K, Nakano K, Kasai H, Arita H. Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells. Biochem Pharmacol 1990; 40: 2535-42.
14. Johnstone MT, Lam JYT, Lacoste L, Baribeau J, Theroux P, Waters D. Methylene blue inhibits the antithrombotic effect of nitroglycerin. J Am Coll Cardiol 1993; 20: 255-9.
15. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992; 20: 1284-93. (Review)
16. Bauters C, Lablanche JM, McFadden EP, Hamon M, Bertrand ME. Relation of coronary angioscopic findings at coronary angioplasty to angiographic restenosis. Circulation 1995; 92: 2473-9.
17. Topol EJ, Califf RM, Weisman HF, et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators. Lancet 1994; 343: 881-6.
18. Friedman RJ, Stemerman MB, Wenz B, et al. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits: smooth muscle cell proliferation and re-endothelialization. J Clin Invest 1977; 60: 1191-201.
19. Barnathan ES, Schwartz JS, Taylor L, et al. Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. Circulation 1987; 76: 123-34.
20. Schwartz L, Bourassa MA, Lesperance J, Aldridge HE, Kazim F. Aspirin and dipyridamole in the prevention of restenosis after PTCA. N Eng J Med 1988; 318: 1714-9.
21. Breton HL, Plow EF, Topol EJ. Role of platelets in restenosis after percutaneous coronary revascularization. J Am Coll Cardiol. 1996; 28: 1643-51. (Review)
22. Pakala R, Willerson JT, Benedict CR, Phil D. Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation. Circulation 1997; 96: 2280-6.
23. Ratti S, Quarato P, Casagrande C, Fumagalli R, Corcini. Picotamide, an antithromboxane agent, inhibits the migration and proliferation of arterial myocytes. Eur J Pharmacol 1998; 355: 77-83.
24. Grosser T, Zucker T-P, Schror K, et al. Thromboxane A2 induces cell signaling but requires platelet derived growth factor to act as a mitogen. Eur J Pharmacol 1997; 319: 327-32.
25. Hanasaki K, Nakano K, Kasai H, Arita H, Ohtani K, Doteuchi M. Specific receptors for thromboxane A2 in cultured vascular smooth muscle cells of rat aorta. Biochem Biophys Res Commun 1988; 150: 1170-5.
26. Lincoff AM, Topol EJ, Ellis SG. Local drug delivery for the prevention of restenosis. Circulation 1994; 90: 2970-84.
27. Muller DWM, Gordon D, Topol EJ, et al. Sustained-release local hirulog therapy decreases early thrombosis but not neointimal thickening after arterial stenting. Am Heart J 1996; 131: 211-8.
28. Efficacy of low-molecular-weight heparin delivery with the Dispatch catheter following balloon angioplasty in the rabbit iliac artery. Cathet Cardiovasc Diagn 1997; 41: 303-7.
29. Hillegas WB, Ohman EM, Califf RM. Restenosis: the clinical issue. In: Topol EJ, editor. Textbook of Interventional Therapy. Philadelphia, PA: WB Saunders, 1994; 415-35.